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Gear Up for Election 2012Three years after federal restrictions on
human embryonic stem cell (hESC)
research were eased, advocates are
again battling to defend the work from
the threat of political upheaval. The prog-
ress made since 2009, when President
Obama overturned restrictions on publicly
funded hESC research enacted by the
Bush administration, could be jeopar-
dized in a pen-stroke if a Republican pres-
ident takes office, and at the state level,
a flurry of ‘‘personhood’’ initiatives seek-
ing to grant legal rights to embryos could
shut down research efforts around the
country.
Stem cell research has largely escaped
the spotlight in this Presidential campaign
so far, but it’s far from a comfortable
silence, according to advocates. They
say the field is in great jeopardy, both
from the socially conservative movement
that’s swept to prominence over recent
months, and a legal challenge to federal
funding for the work. As the election
looms, advocacy groups are fighting
back with stronger networks and new
tools and strategies to rally support and
leverage their influence on Capitol Hill
and beyond.
‘‘This field is on shaky ground,’’ says
Bernard Siegel, founder and executive
director of the Florida-based Genetics
Policy Institute (GPI), which supports
stem cell research through advocacy,
education, and strategic collaborations,
and produces the annual World Stem
Cell Summit andWorld Stem Cell Report.
‘‘The situation is much more serious than
it was 4 years ago. There’s a sense of
urgency in the advocacy community.’’
‘‘The political climate right now is quite
concerning,’’ says Eleanor ‘‘Ellie’’ Deho-
ney, vice president of public policy and
programs at Research!America, an alli-
ance of more than 100 member organiza-
tions that promotes funding and aware-
ness for medical and health research.
‘‘There’s definitely a sense of urgency.’’
Mitt Romney has voiced his opposition
to federally funded hESC research, as
have the other Republican candidates,
and if he is elected president, he could
easily reverse the executive order that490 Cell Stem Cell 10, May 4, 2012 ª2012 Elallows federal funding for the work. He
hasn’t always taken such a conservative
stance, though—during his run for
governor ofMassachusetts, Romney sup-
ported research using surplus embryos,
and public funding for such work—and
his past change of heart gives some
stem cell advocates hope that if elected
president, Romney could soften his
stance. ‘‘I think you could reason with
him,’’ Dehoney says. ‘‘He may become
more moderate.’’
It’s not only political perils that have
stem cell advocates on edge, however.
There’s the lingering menace of an unre-
solved lawsuit, ‘‘Sherley v. Sebelius,’’
that in 2010 temporarily halted NIH in-
volvement in the field. The suit, filed by
two adult stem cell researchers, alleges
that federally funded hESC work violates
a lawconcerning research inwhich human
embryos are destroyed or harmed.
‘‘We have a hangover from the past
administration’s restrictions and we still
have a cloud over us in the form of that
lawsuit,’’ Siegel says.
The latest appeal in the case—the
plaintiffs’ challenge to a 2011 district
court ruling in the government’s favor—
was recently heard by the U.S. Court of
Appeals for the District of Columbia
Circuit. The GPI and the Coalition for the
Advancement of Medical Research
(CAMR), which represents more than
100 patient organizations, universities,
scientific societies, and foundations, filed
an amicus brief with the court, supporting
the government.
It could be months before there’s
a ruling in the appeal, although Siegel,
a lawyer who left behind a 30-year career
in the courtroom to establish the GPI in
2003, says the case could take years to
resolve if it’s appealed again.
Responding to the Threats
Prompted in part by the lawsuit, Siegel
launched the Stem Cell Action Coalition
(SCA), a GPI initiative uniting 75 organiza-
tions, including patient groups, academic
institutes, medical philanthropies, and
science and medical societies to advo-
cate for publicly funded hESC research,sevier Inc.and foster public awareness and support
for the work. The coalition has developed
a strong online presence, distributing
news updates, commentary, and action
alerts though Twitter, Facebook, and
other social networks, as well as oper-
ating in other venues to build support at
public events and community gatherings
and serving as a resource for media.
Like other large advocacy groups, SCA
is making the most of the new tools of cy-
ber advocacy to expand their reach and
to energize and empower supporters, be
they patients, researchers, or investors.
Alliances have also been forged be-
tween some of the most powerful advo-
cacy groups like Research!America and
CAMR, and they’re tapping into the
strength of advocacy groups focused on
conditions such as Alzheimer’s disease
and spinal cord injury, which could benefit
from stem cell therapies. By linking estab-
lished networks, hESC advocates have
expanded and strengthened their influ-
ence and are able to respond more deftly
to the challenges and opportunities of an
election year.
‘‘We’re working harder this year,’’
says Dehoney. ‘‘We’re on the Hill more.’’
In particular, Research!America has
continued to push for an increase in fund-
ing for the National Institutes of Health—
the group was ‘‘instrumental’’ in the
successful effort to double the agency’s
budget in 1995, Dehoney says—by
building support among members of the
appropriations committees. ‘‘It’s true that
the squeaky wheel gets the grease,’’ De-
honey says. ‘‘You have to fight loudly
and consistently to make a difference.’’
For CAMR, the battleground is usually
D.C., where the organization has estab-
lished a high profile since it was founded
in 2001. ‘‘We go where the action is,’’
says CAMR president Amy Comstock
Rick. ‘‘If it’s legislation, if it’s an amicus
brief, if it’s an executive order.’’
This election year, CAMR has also
been busy responding to so-called
‘‘personhood’’ initiatives that have
caused controversy in states around the
country, from Virginia to Mississippi to
Nevada. These antiabortion measures
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in vitro fertilization, some forms of birth
control, and even cancer treatment that
could endanger an embryo.
‘‘When people hear that these person-
hood provisions would have all these
unintended, not even thought-through
impacts,’’ Rick says, ‘‘they have a very
negative view of that.’’ CAMR, she says,
has reached out to its member organiza-
tions to ask them to disseminate informa-
tion on the far-reaching effects of the
proposed measures.
‘‘There are trip wires out there in all
these states,’’ Siegel remarks. ‘‘We try to
stay ahead of the curve so that if we
hear about something happening in Mis-
sissippi or Oklahoma we’re not caught
flat-footed.’’ The personhood movement
could ultimately benefit the stem cell
cause by rousing ‘‘groups that are natural
allies in the effort to promote and defend
hESC research,’’ Siegel adds. ‘‘We are
going to continue to broadcast what’s
going on. The patient movement and the
scientific community have to understand
that this is a threat.’’
Research!America hopes to engage
more researchers in the cause, although
Dehoney notes that, ‘‘It’s notoriously
challenging to engage scientists in advo-
cacy..I think it’s going to happen. Grant
rates are so low that they’re starting to feel
the pinch. It’s really important that
researchers not just work in silos and
that they understand that an attack on
any field of scientific research is an attack
on all scientific research. We rely on the
scientific community to be our expert
witnesses.’’
Looking beyond the Lab
While organizations like GPI, CAMR, and
SCA fight to defend federal funding for
hESC research, a relatively new group,
the Alliance for Regenerative Medicine
(ARM), is focused on the translationalagenda. Formed in 2009, ARM promotes
legislative, regulatory, and reimburse-
ment initiatives that help move regenera-
tive medicine technologies toward the
clinic.
‘‘We thought there needed to be an
organization in Washington that repre-
sented all the stakeholders in the regener-
ative medicine community,’’ says ARM
Executive Director Michael Werner, an
attorney. ‘‘When we go and talk to
Congress we can say, ‘Look at our
makeup, we really represent everyone.’’’
‘‘We have to lend our support to the
translational agenda,’’ Siegel says. ‘‘I
think the advocacy movement needs to
get involved with a broader range of
issues.’’ ARM, which now represents
110 regenerative medicine companies,
research institutions, investors, and
patient groups in the U.S. and farther
afield, recently held its annual Legislative
Day on Capitol Hill. More than 100 ARM
representatives and others in the hESC
field met with members of Congress
and administration officials. ‘‘We found
Congress to be quite receptive to
hearing about regenerative medicine,’’
Werner said. ‘‘The more people become
educated about the field, the more they
become supportive.’’
To try to convince politicians and the
public of the value of hESC work,
Research!America is now broadening
the discussion of its benefits beyond the
promise of clinical advances to also high-
light, ‘‘how this actually affects jobs and
the economy at the state and federal
level,’’ Dehoney says. ‘‘Some people
think, oh, it’s just a few lab jobs for people
with Ph.D.s, it’s nothing to dowith me, but
it has everything to do with them. Public
sector dollars fuel private innovation.’’
‘‘Some people were skeptical that the
economic factor would have impact, but
it does,’’ Dehoney adds. Surveys by
Research!America suggest it’s a particu-Cell Stem Celarly persuasive argument at a time when
Americans are concerned that the country
is losing its global edge in science, tech-
nology and healthcare. A recent poll by
the group found that only 23% of Ameri-
cans consider the U.S. first in medical
and health research today, and that an
overwhelming majority (91%) say it’s
important for the country to maintain its
world leadership role.
The Power of Public Opinion
Research!America has been gauging
public attitudes toward medical, health,
and scientific research since 1992, and
polling Americans on stem cell research
since 2002.
‘‘Our polling has said for years that the
majority of Americans favor hESC
research,’’ Dehoney says, a finding that
stem cell advocates say underscores the
importance of educating the public and
politicians about the research.
‘‘The more people learn and under-
stand about the technology, the more
they support it,’’ says Werner.
Research!America regards polling as
a key part of its strategy, Dehoney says,
and the results have fueled the alliance’s
efforts to highlight the gap between public
opinion and political will.
‘‘We know representatives listen to
their constituents,’’ Dehoney says. ‘‘If
Congress wants to roll back to Bush and
beyond, I’d say it’s going to be a steep
climb.’’ Research!America also runs voter
education initiatives that ask presidential
and congressional candidates where
they stand on the matter of hESC
research, and call on voters to press
candidates for answers.
‘‘There’s so much support for hESC
research I have trouble imagining anyone
tolerating it going backward,’’ Rick adds.
‘‘There’s so much exciting work going
on that I can’t imagine Congress putting
a halt to it. I think there’d be an outcry.’’Anna Davison
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